New Arrivals
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
BCP25031 | N-(2-hydroxyethyl)-3-methylquinoxaline-2-carboxamide New | 104634-22-2 |
BCP34041 | Azvudine New | 1011529-10-4 | |
Azvudine is a nucleoside reverse transcriptase inhibitor (NRTI), which exhibits inhibtory effects on HIV, HBV and HCV.
|
BCP11850 | 5-Chlorothiophene-2-carbonyl chloride New | 42518-98-9 |
BCP15801 | PD1-PDL1 inhibitor 1 New | 1675201-83-8 | |
PD1-PDL1 inhibitor 1 is an inhibitor of the PD-1 /PD-Ll protein/protein interaction, is an immunomodulator.
|
BCP30243 | Cathelicidin LL 37 (human) New | 154947-66-7 | |
LL-37 is a human cathelicidin that inhibits viral replication and while also playing a role in host defense against infection.
|
BCP49654 | Bobcat339 hydrochloride New | 2436747-44-1 | |
Bobcat339 hydrochloride is a potent and selective cytosine-based inhibitor of TET enzyme, with the IC50s of 33 μM and 73 μM for TET1 and TET2, respectively.
|
BCP49653 | β-Cyclodextrin New | 7585-39-9 | |
β-Cyclodextrin is a cyclic polysaccharide composed of seven units of glucose (α-D-glucopyranose) linked by α-(1,4) type bonds. β-Cyclodextrin has often been used to enhance the solubility of agents. β-Cyclodextrin has anti-influenza virus H1N1 activities.
|
BCP49652 | α-Cyclodextrine New | 10016-20-3 | |
α-Cyclodextrin is a multifunctional, soluble dietary fiber marketed for use as a fiber ingredient.
|
BCP40517 | Hyodeoxycholic acid New | 83-49-8 | |
Hyodeoxycholic acid is a secondary bile acid, one of the metabolic byproducts of intestinal bacteria.
|
BCP49651 | Boc-NH-PEG(3)-COOH New | 876345-13-0 | |
Boc-NH-PEG(3)-COOH is a cleavable ADC linker used as a linker for antibody-drug conjugates and a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
|
BCP03777 | Ribavirin New | 36791-04-5 | |
Ribavirin is a nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
|
BCP49650 | Luxdegalutamide New | 2750830-09-0 | |
Luxdegalutamide is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. Luxdegalutamide degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.
|
BCP49649 | BI-2493 New | 2937344-16-4 | |
BI-2493 is a structural analogue of BI-2865 that was optimized for in vivo administration.
|
BCP49642 | DATP New | DATP |
BCP14029 | BLZ945 New Hot | 953769-46-5 | |
BLZ945 is a brain-penetrant CSF-1R inhibitor. The biochemical IC50 for CSF-1R is 1 nM, which is >3200-fold higher than its affinity for other kinases.
|
BCP18361 | EPI 001 New | 227947-06-0 | |
EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of ~6 μM and a selective PPAR-gamma modulator.
|
BCP17809 | CPD3615-A8 New | 1508258-32-9 |
BCP39658 | PXS5505 New | 2409963-83-1 | |
PXS5505 is a pan-LOX inhibitor.
|
BCP29135 | Amenamevir New | 841301-32-4 | |
Amenamevir is a helicase-primase inhibitor which has potent antiviral activity against HSVs with an EC50 of 14 ng/mL.
|
BCP48945 | Mitochondrial fusion promoter M1 New | 219315-22-7 | |
Mitochondrial fusion promoter M1 is a mitochondrial dynamic modulator that increases the expression of mitofusin 2, a mitochondrial outer membrane fusion protein, reduces brain mitochondrial dysfunction.
|